HODGKIN'S LYMPHOMA
Clinical trials for HODGKIN'S LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new HODGKIN'S LYMPHOMA trials appear
Sign up with your email to follow new studies for HODGKIN'S LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare cancers: drug trial targets hard-to-treat tumors
Disease control TerminatedThis study tests a drug called XmAb20717 in 140 adults with advanced rare cancers, including mesothelioma, cervical cancer, and Hodgkin's lymphoma. The goal is to see if the drug can shrink tumors and how safe it is. Participants must have measurable disease and be able to follow…
Matched conditions: HODGKIN'S LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 05:37 UTC
-
Supercharged immune cells take on Hard-to-Treat lymphoma
Disease control OngoingThis early-phase study tests a new treatment for people with Hodgkin or non-Hodgkin lymphoma that has come back or not responded to standard therapy. Researchers take a patient's own immune cells (T cells), add a special receptor that targets the CD30 protein found on lymphoma ce…
Matched conditions: HODGKIN'S LYMPHOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 04, 2026 16:19 UTC
-
Doctor talk training aims to ease cancer Survivors' transition
Knowledge-focused OngoingThis study teaches doctors special communication skills to help lymphoma patients move from active treatment into survivorship. About 314 patients with Hodgkin's or Diffuse Large B-cell Lymphoma and their doctors took part. The goal is to see if better doctor-patient conversation…
Matched conditions: HODGKIN'S LYMPHOMA
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 17, 2026 05:36 UTC